Home The Word Brain My Amedeo FAQ Privacy About   

2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.

  Breast Cancer

  Free Subscription

Articles published in Pathology

Retrieve available abstracts of 20 articles:
HTML format

Single Articles

    April 2024
  1. LAMI K, Yoon HS, Parwani AV, Pham HHN, et al
    Validation of prostate and breast cancer detection artificial intelligence algorithms for accurate histopathological diagnosis and grading: a retrospective study with a Japanese cohort.
    Pathology. 2024 Apr 19:S0031-3025(24)00101-6. doi: 10.1016/j.pathol.2024.
    PubMed     Abstract available

  2. ZENGIN HB, Tan PH, Liu R, Smoller BR, et al
    'Eczematous' dermatitis of the nipple: clinical and histopathological differential diagnosis of Paget disease.
    Pathology. 2024;56:300-312.
    PubMed     Abstract available

  3. TAY TKY, Tan GS, Lee SH, Sam XX, et al
    Comparison of an amplicon-based large panel next generation sequencing (NGS) assay with conventional testing methods for MET and HER2 amplification in lung and breast cancers.
    Pathology. 2024;56:325-333.
    PubMed     Abstract available

    March 2024
  4. WU Y, Chen F, Pan L, Chao X, et al
    Diagnostic utility and sensitivities of matrix Gla protein (MGP), TRPS1 and GATA3 in breast cancer: focusing on metastatic breast cancer, invasive breast carcinoma with special features, and salivary gland-type tumours.
    Pathology. 2024 Mar 14:S0031-3025(24)00084-9. doi: 10.1016/j.pathol.2024.
    PubMed     Abstract available

    Predictive and prognostic biomarkers in breast tumours.
    Pathology. 2024;56:186-191.
    PubMed     Abstract available

    January 2024
  6. BAEZ-NAVARRO X, van Bockstal MR, Jager A, van Deurzen CHM, et al
    HER2-low breast cancer and response to neoadjuvant chemotherapy: a population-based cohort study.
    Pathology. 2024 Jan 18:S0031-3025(24)00007-2. doi: 10.1016/j.pathol.2023.
    PubMed     Abstract available

    October 2023
  7. ZENG L, Koh VCY, Tay TKY, Lee AC, et al
    Adenoid cystic carcinoma arising in association with an intraductal papilloma of the breast.
    Pathology. 2023;55:895-897.

    August 2023
  8. CHEN YY, Yang CF, Hsu CY
    The impact of modified staining method on HER2 immunohistochemical staining for HER2-low breast cancer.
    Pathology. 2023 Aug 12:S0031-3025(23)00186-1. doi: 10.1016/j.pathol.2023.

  9. NGUYEN MA, Colebatch AJ, Van Beek D, Tierney G, et al
    NTRK fusions in solid tumours: what every pathologist needs to know.
    Pathology. 2023;55:596-609.
    PubMed     Abstract available

    June 2023
  10. TAN PH
    Refining the classification of breast phyllodes tumours.
    Pathology. 2023;55:437-448.
    PubMed     Abstract available

    April 2023
  11. NAMJOSHI A, Wong DD, Gill J
    A rare case of metastatic endometrial stromal sarcoma mimicking primary breast carcinoma: a diagnostic pitfall.
    Pathology. 2023;55:414-416.

    October 2022
  12. TSANG JY, Shao Y, Poon IK, Ni YB, et al
    Analysis of recurrent molecular alterations in phyllodes tumour of breast: insights into prognosis and pathogenesis.
    Pathology. 2022;54:678-685.
    PubMed     Abstract available

  13. HARB M, Prince DS, Bassan M, Mackenzie S, et al
    Extra-mammary Paget's disease rising from a non-invasive rectal adenoma.
    Pathology. 2022;54:826-828.

    April 2022
  14. ROY SF, Wong J, Latour M, Reichetzer B, et al
    Ductal-type mesonephric duct/remnant hyperplasia: distinguished from lobular or diffuse mesonephric hyperplasia by the presence of a myoepithelial cell layer and micropapillary tufting.
    Pathology. 2022;54:378-381.

    February 2022
  15. LEE W, Law T, Lu Y, Lee TK, et al
    Mitotic counts in one high power field in breast core biopsies is equivalent to counts in 10 high power fields.
    Pathology. 2022;54:43-48.
    PubMed     Abstract available

  16. KATAYAMA A, Toss MS, Parkin M, Ellis IO, et al
    Atypia in breast pathology: what pathologists need to know.
    Pathology. 2022;54:20-31.
    PubMed     Abstract available

  17. HORT A, O'Toole SA, Yunaev M
    An unusual case of invasive lobular carcinoma with abundant extracellular mucin.
    Pathology. 2022;54:138-140.

    January 2022
  18. KUNC M, Peksa R, Cserni G, Izycka-Swieszewska E, et al
    High expression of progesterone receptor may be an adverse prognostic factor in oestrogen receptor-negative/progesterone receptor-positive breast cancer: results of comprehensive re-evaluation of multi-institutional case series.
    Pathology. 2022 Jan 21. pii: S0031-3025(21)00542.
    PubMed     Abstract available

    February 2021
  19. PAVER EC, Cooper WA, Colebatch AJ, Ferguson PM, et al
    Programmed death ligand-1 (PD-L1) as a predictive marker for immunotherapy in solid tumours: a guide to immunohistochemistry implementation and interpretation.
    Pathology. 2021;53:141-156.
    PubMed     Abstract available

  20. RAZVI H, Tsang JY, Poon IK, Chan SK, et al
    INSM1 is a novel prognostic neuroendocrine marker for luminal B breast cancer.
    Pathology. 2021;53:170-178.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Breast Cancer is free of charge.